Singapore Commercial Affairs Department Arrests Singapore First Cord Blood Bank Cordlife Non-Executive Director Zhai Lingyun for Potential Disclosure Breach, Group CFO Thet Hnin Yi Arrested in 2024 March for Potential Disclosure Breach, Cordlife Group Ex-CEO & 4 Directors Previously Arrested for Potential Disclosure Breach, Reported in November 2023 Storage for Cord Blood Cells Not Maintained at Right Temperature
1st August 2024 | Hong Kong
The Singapore Commercial Affairs Department (CAD) has arrested Singapore first cord blood bank Cordlife Non-Independent & Non-Executive Director Zhai Lingyun for potential disclosure breach. In 2024 March, the Singapore Commercial Affairs Department (CAD) had arrested Cordlife Group CFO Thet Hnin Yi for potential disclosure breach (Released on bail). The Singapore Commercial Affairs Department (CAD) had previously arrested ex-CEO & 4 directors for potential disclosure breach, which was reported in November 2023 of storage for cord blood cells were not maintained at the right temperature. The 5 arrested are ex-CEO Tan Poh Lan, and 4 directors, Dr Ho Choon Hou, Yeo Hwee Tiong, Cheong Tuck Yan Titus Jim & Chow Wai Leong. Cordlife Group CFO Thet Hin Yi assisted with the investigations. 4 other directors who are not based in Singapore had been told to report for interviews (Joseph Wong Wai Leung, Zhai Lingyun, Chen Xiaoling & Yiu Ming Yiu).
“ Singapore Commercial Affairs Department Arrests Singapore First Cord Blood Bank Cordlife Non-Executive Director Zhai Lingyun for Potential Disclosure Breach, Group CFO Thet Hnin Yi Arrested in 2024 March for Potential Disclosure Breach, Cordlife Group Ex-CEO & 4 Directors Previously Arrested for Potential Disclosure Breach, Reported in November 2023 Storage for Cord Blood Cells Not Maintained at Right Temperature “
Singapore Commercial Affairs Department Arrests Singapore First Cord Blood Bank Cordlife Group CFO for Potential Disclosure Breach, Cordlife Group Ex-CEO & 4 Directors Previously Arrested for Potential Disclosure Breach, Reported in November 2023 Storage for Cord Blood Cells Not Maintained at Right Temperature
30th March 2024 – The Singapore Commercial Affairs Department (CAD) has arrested Singapore first cord blood bank Cordlife Group CFO Thet Hnin Yi for potential disclosure breach (Released on bail). The Singapore Commercial Affairs Department (CAD) had previously arrested ex-CEO & 4 directors for potential disclosure breach, which was reported in November 2023 of storage for cord blood cells were not maintained at the right temperature. The 5 arrested are ex-CEO Tan Poh Lan, and 4 directors, Dr Ho Choon Hou, Yeo Hwee Tiong, Cheong Tuck Yan Titus Jim & Chow Wai Leong. Cordlife Group CFO Thet Hin Yi assisted with the investigations. 4 other directors who are not based in Singapore had been told to report for interviews (Joseph Wong Wai Leung, Zhai Lingyun, Chen Xiaoling & Yiu Ming Yiu).
Singapore Commercial Affairs Department Arrests Singapore First Cord Blood Bank Cordlife Group Ex-CEO & 4 Directors for Potential Disclosure Breach, Reported in November 2023 Storage for Cord Blood Cells Not Maintained at Right Temperature, 5 Arrested are Ex-CEO Tan Poh Lan & 4 Directors, Dr Ho Choon Hou, Yeo Hwee Tiong, Cheong Tuck Yan Titus Jim & Chow Wai Leong, CFO Thet Hin Yi Assisted with Investigations, 4 Other Directors Who Are Not Based in Singapore Told to Report for Interviews
23rd March 2024 – The Singapore Commercial Affairs Department (CAD) has arrested Singapore first cord blood bank Cordlife Group ex-CEO & 4 directors for potential disclosure breach, which was reported in November 2023 of storage for cord blood cells were not maintained at the right temperature. The 5 arrested are ex-CEO Tan Poh Lan, and 4 directors, Dr Ho Choon Hou, Yeo Hwee Tiong, Cheong Tuck Yan Titus Jim & Chow Wai Leong. Cordlife Group CFO Thet Hin Yi assisted with the investigations. 4 other directors who are not based in Singapore had been told to report for interviews (Joseph Wong Wai Leung, Zhai Lingyun, Chen Xiaoling & Yiu Ming Yiu).
Cordlife Group
Established in May 2001, Cordlife Group Limited (“Cordlife”, together with its subsidiaries, the “Group”) is a leading company dedicated to safeguarding the well-being of mother and child. The Group is listed on the Mainboard of the Singapore Exchange since 2012 and is a pioneer in private cord blood banking in Asia. Cordlife operates Asia’s largest network of cord blood banks. With full stem cell banking facilities in six key markets, Cordlife is an industry leader in Singapore, Hong Kong, Indonesia and the Philippines, and one of the top three market leaders in India and Malaysia. Through its majority-owned subsidiary in Malaysia, Stemlife Berhad, Cordlife has an indirect stake in Thailand’s largest private cord blood bank, Thai Stemlife. In addition to cord blood, cord lining and cord tissue banking, Cordlife offers families a comprehensive suite of diagnostics services, including non-invasive prenatal testing, paediatric vision screening and newborn metabolic screening.
In January 2018, Cordlife became the market leader in Hong Kong with the acquisition of the largest private cord blood bank, Healthbaby Biotech (Hong Kong) Co., Limited. Through its majority-owned subsidiary in Malaysia, Stemlife Berhad, Cordlife holds an indirect stake in Thailand’s largest private cord blood bank, Thai Stemlife. Cordlife has also established its presence in Myanmar, Vietnam, Macau, Brunei and Bangladesh. In addition to cord blood, cord lining, and cord tissue banking, Cordlife offers families a comprehensive suite of diagnostics services, such as non-invasive prenatal testing, paediatric vision screening, and newborn metabolic screening. At Cordlife, our primary commitment revolves around two key areas: ensuring reliable quality and placing you, our valued customer, at the centre of everything we do. Our mission is to make transfusion medicine and biotherapies safe, available, and effective on a global scale. We strive to maintain the highest standards in cord blood banking for your confidence and well-being. In the area of clinical diagnostics, Cordlife India and Healthbaby Hong Kong are both accredited by the College of American Pathologists (“CAP”). This makes Healthbaby Hong Kong the only private cord blood bank in the world to be accredited by three international standard-setting bodies, and Cordlife India is one of the only two medical laboratories in West Bengal to be holding accreditations from the National Accreditation Board for Testing and Calibration Laboratories (“NABL”) and CAP. These quality achievements reinforce the Group’s commitment to providing reliable healthcare solutions through innovation and technological advancement.
Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2024 Investment Day
- March 2024 - Hong Kong
- March 2024 - Singapore
- July 2024 - Hong Kong
- July 2024 - Singapore
- Sept 2024 - Hong Kong
- Sept 2024 - Singapore
- Oct 2024 - Hong Kong
- Nov 2024 - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
